Table 3. All-grade treatment-related AEs: SAS cluster.
AEs | TACE (N=20) | |
---|---|---|
Grade 1–2 | ≥ Grade 3 | |
All adverse reactions | 19 [95] | 1 [5] |
Nausea and vomiting | 7 [35] | 0 |
Dull pain in upper abdominal liver region | 6 [30] | 1 [5] |
Right upper abdominal distension and pain | 5 [25] | 0 |
Epigastric pain | 3 [15] | 0 |
Stomachache | 3 [15] | 0 |
Slight fever | 2 [10] | 0 |
Fatigue | 2 [10] | 0 |
Dizziness | 1 [5] | 0 |
Upper abdominal pain | 1 [5] | 0 |
Polypnea | 1 [5] | 0 |
Pain and swelling under the xiphoid process | 1 [5] | 0 |
Data are presented as n [%]. AEs, adverse events; SAS, safety analysis set; TACE, transarterial chemoembolization.